Endocyte (ECYT) Misses Q2 EPS by 7c

Endocyte (NASDAQ: ECYT) reported Q2 EPS of ($0.33), $0.07 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Endocyte (ECYT) click here.

You May Also Be Interested In

• Are we witnessing a fundamental or speculative rally in the S&P 500?
• PVH Corp. (PVH) Tops Q1 EPS by 19c, Offers Guidance
• Broadcom results, guidance beat on soaring AI chip sales; stock slips after hours